LOW DISEASE ACTIVITY

Open Access
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, Alvin F. Wells, Martin Bergman, Dafna D. Gladman, Sven Richter, Lichen Teng, Shauna Jardon and Josef S. Smolen

The Journal of Rheumatology July 1 2022, 49 (7) 694-699; DOI: https://doi.org/10.3899/jrheum.210906
You have access
Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes
Katie Bechman, Lieke Tweehuysen, Toby Garrood, David L. Scott, Andrew P. Cope, James B. Galloway and Margaret H.Y. Ma

The Journal of Rheumatology November 1 2018, 45 (11) 1515-1521; DOI: https://doi.org/10.3899/jrheum.171375
You have access
Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study
Till Uhlig, Elisabeth Lie, Vibeke Norvang, Åse Stavland Lexberg, Erik Rødevand, Frode Krøll, Synøve Kalstad, Inge C. Olsen and Tore K. Kvien

The Journal of Rheumatology April 1 2016, 43 (4) 716-723; DOI: https://doi.org/10.3899/jrheum.151132
You have access
Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments
Laura C. Coates and Philip S. Helliwell

The Journal of Rheumatology February 1 2016, 43 (2) 371-375; DOI: https://doi.org/10.3899/jrheum.150826

Main menu